Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabassome Simon

Showing results (141-150 of 272) with videos related to

Pageof 28
Sort By:
International Journal of Cardiology|March 8, 2017
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational studyShaun G Goodman, Jose C Nicolau, Gema Requena, et al.
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
European Journal of Preventive Cardiology|August 28, 2024
Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in womenOrianne Weizman, Marie Hauguel-Moreau, Victoria Tea, et al.
International Journal of Cardiology|December 16, 2014
Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: insights from the French FAST-MI program over 15 yearsEtienne Puymirat, François Schiele, Philippe Gabriel Steg, et al.
Journal of Clinical Lipidology|June 13, 2020
Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction programNicolas Danchin, Michel Farnier, Marianne Zeller, et al.
Functional & Integrative Genomics|May 21, 2024
Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort studyRoberta Armignacco, Nicolas Carlier, Anne Jouinot, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 17, 2018
LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II trialBassam Haddad, Guillaume Lefèvre, Alexandra Rousseau, et al.
The Lancet. Respiratory Medicine|October 24, 2025
D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional studyMélanie Roussel, Héloïse Bannelier, Soufiane Lebal, et al.
International Journal of Cardiology|September 17, 2021
Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 studyHafid Ait-Oufella, Mengyao Yu, Salma Kotti, et al.
The American Journal of Medicine|November 28, 2013
NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic diseasePayal Kohli, Ph Gabriel Steg, Christopher P Cannon, et al.
Pageof 28

Showing results (141-150 of 272) with videos related to

Sort By:
Pageof 28
International Journal of Cardiology|March 8, 2017
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational studyShaun G Goodman, Jose C Nicolau, Gema Requena, et al.
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
European Journal of Preventive Cardiology|August 28, 2024
Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in womenOrianne Weizman, Marie Hauguel-Moreau, Victoria Tea, et al.
International Journal of Cardiology|December 16, 2014
Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: insights from the French FAST-MI program over 15 yearsEtienne Puymirat, François Schiele, Philippe Gabriel Steg, et al.
Journal of Clinical Lipidology|June 13, 2020
Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction programNicolas Danchin, Michel Farnier, Marianne Zeller, et al.
Functional & Integrative Genomics|May 21, 2024
Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort studyRoberta Armignacco, Nicolas Carlier, Anne Jouinot, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 17, 2018
LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II trialBassam Haddad, Guillaume Lefèvre, Alexandra Rousseau, et al.
The Lancet. Respiratory Medicine|October 24, 2025
D-Dimer thresholds for diagnosis of pulmonary embolism based on a single question: is it the most likely diagnosis? A prospective, multicentre, open-label, single-arm interventional studyMélanie Roussel, Héloïse Bannelier, Soufiane Lebal, et al.
International Journal of Cardiology|September 17, 2021
Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 studyHafid Ait-Oufella, Mengyao Yu, Salma Kotti, et al.
The American Journal of Medicine|November 28, 2013
NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic diseasePayal Kohli, Ph Gabriel Steg, Christopher P Cannon, et al.
Pageof 28